Maze Therapeutics (MAZE) Stock Chart & Stock Price History $27.11 +0.61 (+2.30%) As of 10/3/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Maze Therapeutics Stock Price Performance The Maze Therapeutics (MAZE) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has increased 80.25%, reflecting recent market activity. As of the latest close, Maze Therapeutics traded at $27.11 with a market cap of $1.19 billion and volume of 405,456 shares. Receive MAZE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Maze Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+7.58%1 Month Performance+80.25%3 Month Performance+135.74% MAZE Stock Chart for Saturday, October, 4, 2025 MAZE Chart by TradingView Maze Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/03/2025$26.50$27.11+2.30%$27.80$25.88405,456 shs$1.19 billion10/02/2025$25.81$26.50+2.67%$26.79$24.99305,509 shs$1.16 billion10/01/2025$25.93$25.81-0.46%$26.39$25.45307,669 shs$1.13 billion09/30/2025$25.20$25.93+2.90%$26.45$24.42479,937 shs$1.14 billion09/29/2025$27.00$25.20-6.67%$27.83$24.85476,334 shs$1.11 billion09/26/2025$26.35$27.00+2.47%$28.37$26.04609,163 shs$1.18 billion09/25/2025$26.18$26.35+0.65%$27.67$25.90747,137 shs$1.16 billion09/24/2025$24.88$26.18+5.23%$27.65$24.97975,877 shs$1.15 billion09/23/2025$23.67$24.88+5.11%$25.17$23.34430,614 shs$1.09 billion09/22/2025$22.94$23.67+3.18%$24.02$22.45500,659 shs$1.04 billion Get the Latest News and Ratings for MAZE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Maze Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/19/2025$23.48$22.94-2.30%$24.32$22.502.55 million shs$1.01 billion09/18/2025$23.50$23.48-0.09%$24.68$23.01547,976 shs$1.03 billion09/17/2025$23.46$23.50+0.17%$24.49$22.89498,392 shs$1.03 billion09/16/2025$23.25$23.46+0.90%$25.18$22.59390,820 shs$1.03 billion09/15/2025$23.30$23.25-0.21%$23.42$22.04556,508 shs$1.02 billion09/12/2025$24.80$23.30-6.05%$25.48$22.011.27 million shs$1.02 billion09/11/2025$16.02$24.80+54.81%$25.50$20.005.07 million shs$1.09 billion09/10/2025$16.34$16.02-1.96%$17.45$15.70300,947 shs$702.49 million09/09/2025$14.97$16.34+9.15%$17.07$14.75473,258 shs$716.51 million09/08/2025$15.88$14.97-5.73%$16.05$14.90270,202 shs$656.43 million09/05/2025$15.04$15.88+5.59%$16.20$14.27309,623 shs$696.34 million09/04/2025$15.19$15.04-0.99%$15.68$14.16354,913 shs$659.52 million09/03/2025$15.32$15.19-0.85%$16.40$14.86390,311 shs$666.08 million Related Companies PTC Therapeutics Stock Chart Jyong Biotech Stock Chart Arrowhead Pharmaceuticals Stock Chart Arcellx Stock Chart Vaxcyte Stock Chart Protagonist Therapeutics Stock Chart Kymera Therapeutics Stock Chart ADMA Biologics Stock Chart Akero Therapeutics Stock Chart Mirum Pharmaceuticals Stock Chart Receive MAZE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Maze Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MAZE) was last updated on 10/4/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredChina’s New Gold Play Could Make your Income SoarChina's New Gold Move Could Pay You up to $1,152/month. China just announced plans to store other nations' ...Investors Alley | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredLost Decade warning – do this nowWith the Magnificent 7 trading at bubble-like valuations, another “Lost Decade” could be looming — but Porter ...Porter & Company | SponsoredU.S. Government Sparking Crypto RallySecond Chances Don't Come Often in Crypto My "Crypto Bull Run Millionaire Blueprint" reveals everything - w...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Maze Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Maze Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
